Research Peptides in Brookings, SD

Shipping research peptides to Brookings

Peptides Factory Direct delivers third-party-tested research peptides to Brookings and the surrounding South Dakota area. Orders ship as stable lyophilized vials ready for refrigerated storage and reconstitution in your lab. Whether you are part of a university group, a private research facility, or an independent Brookings researcher, every lot meets the same 99%+ purity target with a Certificate of Analysis on request, identity confirmed by mass spectrometry and purity quantified by HPLC.

Research peptide categories shipped to Brookings

Brookings researchers can order across all seven research categories in the catalog. The table below maps each category to what it is studied for and example compounds.

Research peptides Brookings researchers request most

Below are the research peptides Brookings laboratories most often order. Each summary reflects the published research literature and is provided for laboratory context only, and every compound is research-use-only and is not for human or animal consumption.

IGF-1 LR3 (Long R3 Insulin-like Growth Factor 1) research

IGF-1 LR3 is a modified, long-acting analog of insulin-like growth factor 1, with an 83-amino-acid structure and a reduced affinity for binding proteins that gives it an extended active half-life in research models.

Research mechanism. IGF-1 LR3 research focuses on IGF-1-receptor activation driving cell proliferation, nutrient partitioning, and anabolic signaling. Its extended half-life is the defining research feature versus native IGF-1.

Anabolic / growth research. Among the most-studied peptides for cellular growth and protein-synthesis models.

Nutrient-partitioning research. Studied for its reported influence on substrate handling.

Recovery models. Examined for tissue-recovery endpoints in cycled research designs.

How it compares. Where GHRPs and GHRH analogs stimulate endogenous GH, IGF-1 LR3 supplies a downstream IGF signal directly, making it a distinct and more advanced research tool.

Research pairings. IGF-1 LR3 is studied in cycled designs rather than continuous use, sometimes following GH-secretagogue protocols.

Reference research values. Research references commonly cite 40-80 mcg daily in 4-6 week cycled study windows. Reference values only - an advanced research compound.

Full IGF-1 LR3 research profile → · Growth Hormone & Muscle peptides

Semax (BDNF nootropic) research

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), developed in Russia. It is studied for cognitive and neuroprotective endpoints and is one of the most-cited nootropic research peptides.

Research mechanism. Semax research focuses on up-regulation of BDNF and nerve-growth-factor signaling and on modulation of monoamine systems, with interest in learning, memory, and neuroprotection endpoints.

Cognitive / focus research. Studied for attention, learning, and memory endpoints.

Neuroprotection research. Examined in models of neural stress and recovery.

BDNF-signaling research. A model compound for neurotrophic-factor studies.

How it compares. Semax is studied more for focus and BDNF, Selank more for anxiety; N-Acetyl Semax Amidate is a more potent, longer-lasting analog.

Research pairings. Semax + Selank pairs focus and anxiety endpoints in cognitive research.

Reference research values. Research references commonly cite 300-600 mcg daily across 2-4 week cycles. Reference values only.

Full Semax research profile → · Cognitive & Neurological peptides

Adamax (Nootropic Peptide Analog) research

Adamax is a synthetic nootropic peptide analog discussed in neuroprotection and cognitive research. It sits in the nootropic-peptide family alongside compounds like Semax and Selank, and is examined for neurotrophic and neuroprotective signaling in research models.

Research mechanism. Adamax research focuses on neurotrophic and neuroprotective signaling - including interest in BDNF-related pathways and neuro-recovery endpoints - as a short-acting nootropic peptide analog.

Cognitive / nootropic research. Studied for attention, memory, and cognitive-performance endpoints in models.

Neuroprotection research. Examined for neuroprotective and neurotrophic signaling.

Neuro-recovery research. Investigated in recovery-oriented neurological research designs.

How it compares. Adamax is a synthetic nootropic analog, distinct from the bioregulator Pinealon and the well-characterized Semax/Selank nootropics, and is treated as a more advanced research compound.

Research pairings. Studied alongside other nootropic peptides such as Semax and Selank in cognitive-research designs.

Reference research values. Research references commonly cite 250-1000 mcg daily depending on the cognitive-research objective, often in an intranasal model. Reference values only - not for human or animal use.

Full Adamax research profile → · Cognitive & Neurological peptides

Melanotan I (Afamelanotide) research

Melanotan I (afamelanotide) is a linear analog of alpha-MSH that is more selective than Melanotan II, studied for melanogenesis endpoints with fewer of the off-target effects reported for MT-II.

Research mechanism. Melanotan I research focuses on MC1R-mediated melanin synthesis, the pathway central to pigmentation research, with a more selective profile than the non-selective MT-II.

Pigmentation research. Studied for melanogenesis endpoints with a selective profile.

Photoprotection research. Examined in models of UV response.

Melanocortin-receptor research. A more selective MC1R model compound.

How it compares. Melanotan I is more selective and reportedly better tolerated in models than Melanotan II, with a narrower pigmentation focus.

Research pairings. Generally studied as a standalone selective melanocortin agonist.

Reference research values. Research references commonly cite a loading figure of 0.5-1 mg daily followed by 2-3 times weekly maintenance. Reference values only.

Full Melanotan I research profile → · Sexual Health & Tanning peptides

Tesamorelin (GHRH analog) research

Tesamorelin is a stabilized analog of growth-hormone-releasing hormone studied for its reported effect on visceral adipose tissue - the fat surrounding internal organs - in metabolic research models.

Research mechanism. Tesamorelin stimulates endogenous GH release like other GHRH analogs, with research focused specifically on visceral-fat endpoints rather than subcutaneous fat.

Visceral-fat research. Studied specifically for visceral adipose tissue endpoints.

Metabolic-health models. Examined for broader metabolic-syndrome research variables.

GHRH-axis research. Used as a GHRH analog in GH-release studies.

How it compares. Tesamorelin is studied for visceral fat specifically, distinguishing it from AOD 9604 (general lipolysis) and the GLP-1 peptides (appetite).

Research pairings. Studied as a standalone GHRH analog in metabolic research.

Reference research values. Research references commonly cite 1-2 mg daily. Reference values only.

Full Tesamorelin research profile → · Fat Loss & Weight Management peptides

Thymosin Alpha-1 (immune peptide) research

Thymosin Alpha-1 is a 28-amino-acid peptide originally isolated from the thymus gland. It is a well-studied immune-modulation research peptide with an extensive literature on T-cell signaling.

Research mechanism. Thymosin Alpha-1 research focuses on modulation of T-cell maturation and innate immune signaling, making it a model compound for immune and antiviral research.

Immune-modulation research. The central theme - T-cell and innate-immune signaling models.

Antiviral research. Studied in models of immune response to viral challenge.

Longevity / immune-aging research. Examined in immunosenescence designs.

How it compares. Thymosin Alpha-1 targets immune signaling, distinguishing it from telomere-focused Epithalon and the structural healing peptides.

Research pairings. Sometimes studied alongside Epithalon in immune-and-aging research designs.

Reference research values. Research references commonly cite 0.5-1 mg two to three times weekly. Reference values only.

Full Thymosin Alpha-1 research profile → · Anti-Aging & Longevity peptides

Epithalon (Epitalon) research

Epithalon (Epitalon) is a synthetic tetrapeptide based on a naturally occurring pineal peptide. It is one of the most-cited peptides in longevity research because of its reported association with telomerase activity and telomere length in study models.

Research mechanism. Epithalon research focuses on potential activation of telomerase - the enzyme that maintains telomeres - and on pineal/melatonin-axis regulation, both of which are longevity-research variables.

Telomere and longevity research. The central research theme, studying telomerase and cellular-aging endpoints.

Pineal / circadian research. Examined for melatonin-axis and sleep-regulation variables.

Cellular-aging models. Used in broad aging-research designs.

How it compares. Epithalon is studied for telomere/longevity endpoints specifically, distinguishing it from immune-focused Thymosin Alpha-1 and cognitive peptides.

Research pairings. Studied as a standalone longevity peptide, sometimes alongside Thymosin Alpha-1 in aging-research designs.

Reference research values. Research references commonly cite 1 mg daily across a 10-day cycle, repeated every 3-6 months. Reference values only.

Full Epithalon research profile → · Anti-Aging & Longevity peptides

GHK-Cu (Copper Peptide) research

GHK-Cu is a naturally occurring copper-binding tripeptide (glycyl-L-histidyl-L-lysine bound to copper). It is one of the most studied peptides in regenerative and dermatological research because of its role in copper transport and remodeling of the extracellular matrix.

Research mechanism. Research associates GHK-Cu with stimulation of collagen and elastin synthesis, antioxidant and anti-inflammatory signaling, and modulation of genes involved in tissue remodeling. The injectable form is studied separately from topical cosmetic applications.

Skin and tissue regeneration research. GHK-Cu is studied for wound-model healing, extracellular-matrix remodeling, and collagen synthesis.

Hair-follicle research. It appears frequently in hair-growth and follicle-signaling research models.

Anti-inflammatory and antioxidant studies. Its copper-transport role is studied for redox and inflammation endpoints.

How it compares. GHK-Cu targets skin, hair, and matrix research where BPC-157 and TB-500 target connective and muscle tissue, so it covers a distinct research niche.

Research pairings. In regenerative research GHK-Cu is sometimes paired with BPC-157 or TB-500 to model both structural and dermal repair.

Reference research values. Research references commonly cite 1-2 mg administered 3-5 times per week. Reference values only.

Full GHK-Cu research profile → · Healing & Recovery peptides

TB-500 (Thymosin Beta-4 fragment) research

TB-500 is a synthetic peptide corresponding to the active region of Thymosin Beta-4, a naturally occurring protein involved in actin regulation and cell migration. In research it is valued for its reported ability to travel systemically and reach tissue throughout the body rather than acting only at a local site.

Research mechanism. TB-500 research focuses on its binding to G-actin and its role in cell migration, blood-vessel formation, and the recruitment of repair cells to damaged tissue. By promoting cell motility, it is studied as a driver of slower but deeper regeneration than localized repair peptides.

Deep tissue and muscle recovery research. TB-500 is studied across muscle, tendon, and ligament models where whole-body distribution is desirable, and in flexibility and range-of-motion research.

Chronic-injury models. Its systemic profile makes it common in chronic and hard-to-reach injury models where a localized peptide would be impractical.

Stacked regeneration studies. It is the standard research partner for BPC-157 in connective-tissue regeneration protocols.

How it compares. Where BPC-157 is studied as fast and local, TB-500 is studied as slower and systemic. Researchers often choose between them based on whether whole-body distribution or site-specific action is the variable of interest.

Research pairings. TB-500 + BPC-157 is the most-studied healing pair in the literature; the two are reported to address complementary repair pathways. TB-500 is banned by WADA, a relevant note for sports-science researchers.

Reference research values. Published research references commonly cite a loading phase of 5-10 mg per week split across 2-3 administrations for 4-6 weeks, followed by a 2-5 mg per week maintenance figure. These are reference values from the literature and are not instructions for any living subject.

Full TB-500 research profile → · Healing & Recovery peptides

Ovagen (Organ Bioregulator) research

Ovagen is a peptide bioregulator from the Khavinson family, studied for reproductive and organ tissue-support concepts in research models. Peptide bioregulators are investigated for tissue-specific normalization of gene expression and protein synthesis.

Research mechanism. Ovagen research centers on tissue-specific peptide bioregulation - the concept that short peptides can support normal function and protein synthesis in their target organ tissue - within reproductive and organ-support research models.

Reproductive-tissue research. Studied for reproductive and organ tissue-support endpoints in models.

Organ-support research. Examined in bioregulator research focused on tissue normalization concepts.

Longevity bioregulator research. Investigated within the broader Khavinson bioregulator research framework.

How it compares. Ovagen is an organ/reproductive-tissue bioregulator, distinct from the vascular bioregulator Vesugen and the neuro bioregulator Pinealon.

Research pairings. Studied alongside other Khavinson bioregulators (Epithalon, Vesugen, Pinealon) in organ-support research designs.

Reference research values. Research references commonly cite 2-5 mg daily in short-course bioregulator study cycles. Reference values only - not for human or animal use.

Full Ovagen research profile → · Specialty peptides

Hexarelin (potent GHRP) research

Hexarelin is a synthetic hexapeptide and one of the most potent growth-hormone-releasing peptides studied in research, with reported activity beyond GH release including cardiovascular-tissue signaling.

Research mechanism. Hexarelin strongly activates the GH-secretagogue receptor. Research notes desensitization with continuous exposure and increases in prolactin and cortisol, so cycled study designs are common.

Potent GH-release research. Studied where maximal GH-pulse stimulation is the variable.

Cardiac-tissue research. Examined for reported GH-independent cardiovascular signaling.

Cycled GHRP designs. Used in research that models receptor desensitization.

How it compares. Hexarelin is the most potent GHRP studied here but with the most off-target signaling and desensitization, contrasting with the gentler Ipamorelin.

Research pairings. Hexarelin is studied in cycled designs and monitored for prolactin/cortisol; it is rarely combined continuously with other GHRPs.

Reference research values. Research references commonly cite 100-200 mcg two to three times daily across 4-8 week cycles. Reference values only.

Full Hexarelin research profile → · Growth Hormone & Muscle peptides

GHRP-2 (Growth Hormone Releasing Peptide-2) research

GHRP-2 is a synthetic hexapeptide growth-hormone secretagogue, studied as a middle ground between GHRP-6 (strong appetite signaling) and Ipamorelin (selective and clean).

Research mechanism. GHRP-2 activates the GH-secretagogue receptor for GH release, with a reportedly smaller appetite response than GHRP-6 and somewhat more than Ipamorelin in research models.

GH-release research. A potent GHRP for growth-hormone-pulse studies.

Body-composition models. Studied for downstream metabolic endpoints.

GHRH synergy research. Paired with CJC-1295 in stacking studies.

How it compares. GHRP-2 is studied as a balance between GHRP-6 potency/appetite and Ipamorelin selectivity.

Research pairings. GHRP-2 + CJC-1295 is a common research pairing; prolactin is monitored in models.

Reference research values. Research references commonly cite 100-300 mcg two to three times daily. Reference values only.

Full GHRP-2 research profile → · Growth Hormone & Muscle peptides

CJC-1295 (with or without DAC) research

CJC-1295 is a synthetic analog of growth-hormone-releasing hormone (GHRH). It is studied in two forms: "no DAC" (also called Mod GRF 1-29), which is short-acting, and "with DAC" (Drug Affinity Complex), which binds albumin for a markedly longer half-life in research models.

Research mechanism. CJC-1295 research focuses on stimulation of the pituitary to release growth hormone in pulses. The DAC version extends the active window, while the no-DAC version produces a sharper, shorter pulse often studied alongside a GHRP such as Ipamorelin for synergistic release.

Growth-hormone release research. The central research theme is endogenous GH-pulse stimulation and the comparison of DAC vs no-DAC kinetics.

Body-composition models. It is studied for downstream effects on muscle and fat metabolism in research models.

GHRH + GHRP synergy studies. CJC-1295 + Ipamorelin is one of the most-studied research pairings for amplified GH pulses.

How it compares. The DAC form trades fewer administrations for a longer, flatter profile; the no-DAC form is studied for sharper, more physiologic pulses. Choice depends on the research kinetics of interest.

Research pairings. CJC-1295 (no DAC) + Ipamorelin is the canonical research pairing; the GHRH analog and the GHRP are reported to act through complementary receptors.

Reference research values. Research references commonly cite 200-300 mcg of the no-DAC form before rest periods on a 5-7 day schedule, or 1-2 mg of the DAC form one to two times weekly. Reference values only.

Full CJC-1295 research profile → · Growth Hormone & Muscle peptides

Research applications studied in Brookings

• Anabolic / growth research (IGF-1 LR3). Among the most-studied peptides for cellular growth and protein-synthesis models.
• Cognitive / focus research (Semax). Studied for attention, learning, and memory endpoints.
• Cognitive / nootropic research (Adamax). Studied for attention, memory, and cognitive-performance endpoints in models.
• Pigmentation research (Melanotan I). Studied for melanogenesis endpoints with a selective profile.
• Visceral-fat research (Tesamorelin). Studied specifically for visceral adipose tissue endpoints.

How Brookings researchers order and store material

Ordering for a Brookings lab is done in the Peptides Factory Direct portal, with one-time or recurring options and a checkout confirmation of laboratory research use. Material ships to Brookings as a lyophilized powder for refrigerated storage; after reconstitution keep it cold and use within the standard research window. Brookings researchers remain responsible for compliance with applicable law, and nothing supplied is for human or animal consumption. Open the order portal.

Why Brookings researchers choose Peptides Factory Direct

What sets Peptides Factory Direct apart for Brookings researchers is documentation, not claims. Each Brookings order is third-party tested to a 99%+ purity target, ships with lot tracking and a COA on request, and arrives quickly by domestic carrier. The same catalog, purity standard, and research-use terms apply whether material ships to Brookings or anywhere else in the US.

Nearby South Dakota research areas we ship to

Frequently asked questions

All South Dakota cities · All states · Research guides

External references: South Dakota (Wikipedia) · U.S. Census Bureau